A novel nonsense mutation in the MPL gene in congenital amegakaryocytic thrombocytopenia.
Journal: Pediatric Blood & Cancer
Published:
Abstract
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive disorder characterized by thrombocytopenia from failure of megakaryopoiesis. CAMT is one of the bone marrow failure syndromes, and the disease progression may involve other lineages leading to pancytopenia. The genetic background of CAMT is mutations in the MPL gene encoding the thrombopoietin receptor. Here, we describe a Korean male with CAMT. Molecular genetic analyses by direct sequencing revealed that he was compound heterozygous for two nonsense mutations in MPL, Tyr63X (c.189C>A), and Arg357X (c.1069C>T), the latter being a novel mutation.
Authors
Hae-sun Chung, Kyung Koh, Hee-jung Kim, Hee-jin Kim, Ki-o Lee, Chan-jeoung Park, Hyun-sook Chi, Sun-hee Kim, Jong-jin Seo, Ho Im
Relevant Conditions